SageGuard Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.84M Sell
4,181
-355
-8% -$419K 0.67% 54
2026
Q2
$5.44M Buy
4,536
+1,042
+30% +$1.06M 0.76% 45
2026
Q1
$3.21M Buy
3,494
+2,236
+178% +$2.27M 0.5% 55
2025
Q4
$1.35M Buy
+1,258
New +$1.2M 0.22% 80
2021
Q3
– Sell
-1,455
Closed -$334K – 77
2021
Q2
$334K Sell
1,455
-8
-0.5% -$1.61K 0.15% 101
2021
Q1
$274K Sell
1,463
-32
-2% -$6.26K 0.13% 107
2020
Q4
$254K Buy
+1,495
New +$223K 0.12% 104

Other funds holding LLY

SageGuard Financial Group's LLY Position: Q3 2026 in Review

SageGuard Financial Group reduced its Eli Lilly (LLY) stake by 7.8% in Q3 2026, selling an estimated $419K and leaving 4,181 shares worth $4.84M. The position accounts for 0.67% of the portfolio, ranked #54.

SageGuard Financial Group first reported a position in LLY in Q4 2020 and has held it in 7 quarters since. The position peaked at $5.44M in Q2 2026. 4,616 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • SageGuard Financial Group held 4,181 shares of Eli Lilly worth $4.84M as of Q3 2026.
  • SageGuard Financial Group sold 355 Eli Lilly shares in Q3 2026, an estimated $419K.
  • Eli Lilly made up 0.67% of SageGuard Financial Group's portfolio in Q3 2026, its #54 holding.
  • SageGuard Financial Group first reported a position in Eli Lilly in Q4 2020 and has held it in 7 quarters since.
  • SageGuard Financial Group's Eli Lilly position peaked at $5.44M in Q2 2026.
  • 4,616 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on SageGuard Financial Group's 13F filing for Q3 2026, filed 12 Nov 2026.